These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35915454)

  • 21. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections.
    McAuley SA; Vogrin S; Lee MH; Paldus B; Trawley S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Jenkins AJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Ward GM; Jones TW; O'Neal DN;
    Diabetes Technol Ther; 2021 Jun; 23(6):460-466. PubMed ID: 33351699
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
    Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
    Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
    Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
    Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technological Developments and Quality of Life in Type 1 Diabetes Mellitus Patients: A Review of the Modern Insulin Analogues, Continuous Glucose Monitoring and Insulin Pump Therapy.
    Benioudakis E; Karlafti E; Kalaitzaki A; Kaiafa G; Savopoulos C; Didangelos T
    Curr Diabetes Rev; 2022; 18(7):e031121197657. PubMed ID: 34732118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does insulin pump therapy improve quality of life and satisfaction in children and adolescents with type 1 diabetes?].
    Lichtenberger-Geslin L; Boudailliez B; Braun K; Bach V; Mercier A; Bony-Trifunovic H
    Arch Pediatr; 2013 Mar; 20(3):248-56. PubMed ID: 23380034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.
    Westen SC; Warnick JL; Albanese-O'Neill A; Schatz DA; Haller MJ; Entessari M; Janicke DM
    J Pediatr Psychol; 2019 Jan; 44(1):21-31. PubMed ID: 30184209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of diabetes mellitus: is the pump mightier than the pen?
    Pickup JC
    Nat Rev Endocrinol; 2012 Feb; 8(7):425-33. PubMed ID: 22371161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial.
    White D; Waugh N; Elliott J; Lawton J; Barnard K; Campbell MJ; Dixon S; Heller S;
    BMJ Open; 2014 Sep; 4(9):e006204. PubMed ID: 25186159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
    Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
    Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
    Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.
    Reznik Y; Cohen O; Aronson R; Conget I; Runzis S; Castaneda J; Lee SW;
    Lancet; 2014 Oct; 384(9950):1265-72. PubMed ID: 24998009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.
    Polonsky WH; Hessler D
    Diabetes Technol Ther; 2013 Apr; 15(4):295-301. PubMed ID: 23427866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus.
    Batajoo RJ; Messina CR; Wilson TA
    J Clin Res Pediatr Endocrinol; 2012 Sep; 4(3):127-31. PubMed ID: 22985612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Choice Should Be Yours: Diabetes-Related Distress by Insulin Delivery Method for People with Type 1 Diabetes.
    Wardian JL; True MW; Folaron I; Colburn J; Tate JM; Beckman DJ
    Diabetes Technol Ther; 2020 Jan; 22(1):42-47. PubMed ID: 31418594
    [No Abstract]   [Full Text] [Related]  

  • 40. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.